Systemic mastocytosis is a rare health condition in which too many mast cells (a type of immune system cell) build up in the ...

Cutaneous mastocytosis (CM) has a low incidence of systemic involvement in children, whereas, systemic mastocytosis (SM) occurs in greater than 25% of adults with CM (Hartmann & Metcalfe ...

The following is a summary of "Comparison of prognostic scores according to WHO classification in 170 patients with advanced ...

Indolent systemic mastocytosis (ISM) is one of the five subtypes of systemic mastocytosis, a condition characterized by the ...

Oncologists’ tendencies to prescribe systemic anticancer therapy at the end of life vary widely, even after adjusting for patient-level and practice-level covariates.

Here’s what else the team learned. In Systemic Mastocytosis, What’s the Impact of Type I Interferon Autoantibodies? Investigators from the National Institutes of Health recently tackled the ...

Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic, describes the steps clinicians should take when they encounter clinical abnormalities that may point to systemic mastocytosis. (1:48 ...

Medscape, September 06, 2024 Fast Five Quiz: Indolent Systemic Mastocytosis How much do you ... drug conjugates in non–small cell lung cancer treatment? Check your knowledge with this quick ...

We want to support clinicians in ensuring all patients are fully informed when consenting to SACT. These forms are endorsed by the UK Systemic Anti-Cancer Therapy Board (UK SACT Board). Who has ...

refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the ...